期刊文献+

慢性肾脏病生物标志物及其检测研究进展 被引量:2

原文传递
导出
摘要 一、生物标志物的定义 生物标志物首先是在1989年作为医学主题词被提出来的,当时定义为“可测量和定量的生物学参数”。2001年,美国国立卫生研究院(NIH)对生物标志物的定义进行了规范,定义为通过客观检测和评价能够预示正常生理、病理过程或机体对药物治疗反应的所有生物学特性川。能够从患者身上检测到的任何参数都可以成为生物标志物,比如mRNA表达谱、各种蛋白质、蛋白质组、脂类、影像学检查或者电信号。
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2009年第6期491-494,共4页 Chinese Journal of Nephrology
基金 国家自然科学基金(30570476) 江苏省自然科学基金重点项目(2007709)
  • 相关文献

参考文献35

  • 1Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther, 2001, 69: 89-95.
  • 2Molitoris BA, Melnikov VY, Okusa MD, et al. Technology Insight: biomarker development in acute kidney injury-what can we anticipate? Nat Clin Pract Nephrol, 2008, 4: 154- 165.
  • 3Oldenhuis CN, Oosting SF, Gietema JA, et al. Prognostic versus predictive value of biomarkers in oncology. Eur J Cancer, 2008, 44: 946-953.
  • 4Veenstra TD. Global and targeted quantitative proteomics for biomarker discovery. J Chromatogr B, 2007, 847: 3-11.
  • 5Lock EA, Bonventre JV. Biomarkers in translation; past, present and future. Toxicology, 2008, 245: 163-166.
  • 6Couser WG, Shah S, Kopple J, et al. A call to action on World Kidney Day, 8 March 2007. Kidney Int, 2007, 71: 369-370.
  • 7Kriz W, LeHir M. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int, 2005, 67: 404-419.
  • 8Schnaper HW, Kopp JB. Why kidneys fail: report from an American Society of Nephrology Advances in Research Conference. J Am Soc Nephrol, 2006, 17: 1777-1781.
  • 9Perco P, Pleban C, Kainz A, et al. Protein biomarkers associated with acute renal failure and chronic kidney disease. Eur J Clin Invest, 2006, 36: 753-763.
  • 10Szeto CC, Chan RW, Lai KB, et al. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases. Nephrol Dial Transplant, 2005, 20: 105-113.

二级参考文献36

共引文献16

同被引文献27

  • 1郭文焕,余英豪,郑智勇.免疫球蛋白肾病组织学分级系统研究进展[J].医学综述,2006,12(1):62-64. 被引量:1
  • 2裘红梅,赵彩红,宋光.联合检测尿液α_1-MG、NAG及尿液Cystatin C对肾损害早期诊断的临床意义[J].大连大学学报,2007,28(3):93-94. 被引量:6
  • 3张洪旭(综述、审校).IgA肾病诊断与治疗进展[J].国际泌尿系统杂志,2007,27(4):572-576. 被引量:1
  • 4Mera J, Uchida S, Nagase M. Clinicopathologic study on prognostic markers in IgA nephropathy. Nephron,2000,84(2) : 148 -157.
  • 5Ajiro A, Uchida K, Honda K, Nitta K, Nihei H. Significance of in- terstitial lesions in IgA nephropathy: a quantitative evaluation of the 'interstitial area using an image analyzer for color extraction. Nippon Jinzo Gakkai Shi,2003,45(2) : 84 -90.
  • 6Yuling H, Ruijing X, Xiang J, et al. CD19 +CD5 + B cells in pri- mary IgA nephropathy. J Am Soc Nephrol, 2008,19( 11 ) :2130 - 2139.
  • 7Rifai A, Dworkin LD. IgA nephropathy: markers of progression and clues to pathogenesis. Kidney Int, 2008,73 (12) :1338 -1340.
  • 8Myllymaki JM, Honkanen TT, Syrjanen JT, et al. Severity of tubu- lointerstitial inflammation and prognosis in immunoglobulin A ne- phropathy. Kidney Int, 2007,71 (4) :343 - 348.
  • 9Peters HP, den Brand JA v, Wetzels JF. Urinary excretion of low - molecular- weight proteins as prognostic markers in IgA nephropa- thy. Neth J Med, 2009,67(2) :54 -61.
  • 10Haubitz M , Wittke S, Weissinger EM, etal. Urine protein patterns can serveas diagnostic tools in patients with lgA nephropathy. Kidney Int,2005,67(6) :2313 -2320.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部